Clearpoint Neuro, Inc. (CLPT) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated February 12, 2020, reports on Clearpoint Neuro, Inc. (formerly MRI Interventions, Inc.), a Delaware corporation listed on the Nasdaq Capital Market. The filing serves to announce the Company's financial performance for the fourth fiscal quarter and the full fiscal year ended December 31, 2019.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not explicitly detail material changes versus prior periods within the body text. It directs readers to the attached press release (Exhibit 99.1) for the announcement of financial performance results.
Guidance, Outlook, and Risks
The filing does not contain specific management commentary, guidance, outlook, or risk factors in the provided text. It notes that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 12, 2020) for specific Q4 and full-year 2019 financial figures.
- Verify the Company's name change from MRI Interventions, Inc. to Clearpoint Neuro, Inc.
- Confirm the trading symbol (CLPT) and exchange (Nasdaq Capital Market) status.
- Check for any forward-looking statements or updated guidance in the attached press release.